Pursuits
URL Pharma, Facebook, Qualcomm, Teva: Intellectual Property
This article is for subscribers only.
A URL Pharma Inc. unit sued Par Pharmaceutical Cos. alleging infringement of 10 patents with its plans to market a generic version of the Colcrys gout treatment.
AR Holding Inc. contends in a complaint filed yesterday in federal court in Wilmington, Delaware, that Par has wrongly applied to the U.S. Food and Drug Administration for approval to sell its copies before the patents expire.